Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLV339 in Pancreatic Exocrine Insufficiency
NCT00630279Phase 2Terminated
- Sponsor
- Solvay
- Start
- Feb 2008
- Primary completion
- Mar 2009
- Modality
- Replacement Enzymes
- Countries
- 7
01
Overview
A Phase 2 trial of SLV339 in pancreatic exocrine insufficiency (EPI), sponsored by Solvay. Started Feb 2008; status: terminated.
02
Drugs
SLV339
03
Conditions
pancreatic exocrine insufficiency (EPI)
Beyond the preview
Go deeper on NCT00630279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630279.